A multi-task graph deep learning model to predict drugs combination of synergy and sensitivity scores.

IF 2.9 3区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS BMC Bioinformatics Pub Date : 2024-10-10 DOI:10.1186/s12859-024-05925-0
Samar Monem, Aboul Ella Hassanien, Alaa H Abdel-Hamid
{"title":"A multi-task graph deep learning model to predict drugs combination of synergy and sensitivity scores.","authors":"Samar Monem, Aboul Ella Hassanien, Alaa H Abdel-Hamid","doi":"10.1186/s12859-024-05925-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Drug combination treatments have proven to be a realistic technique for treating challenging diseases such as cancer by enhancing efficacy and mitigating side effects. To achieve the therapeutic goals of these combinations, it is essential to employ multi-targeted drug combinations, which maximize effectiveness and synergistic effects.</p><p><strong>Results: </strong>This paper proposes 'MultiComb', a multi-task deep learning (MTDL) model designed to simultaneously predict the synergy and sensitivity of drug combinations. The model utilizes a graph convolution network to represent the Simplified Molecular-Input Line-Entry (SMILES) of two drugs, generating their respective features. Also, three fully connected subnetworks extract features of the cancer cell line. These drug and cell line features are then concatenated and processed through an attention mechanism, which outputs two optimized feature representations for the target tasks. The cross-stitch model learns the relationship between these tasks. At last, each learned task feature is fed into fully connected subnetworks to predict the synergy and sensitivity scores. The proposed model is validated using the O'Neil benchmark dataset, which includes 38 unique drugs combined to form 17,901 drug combination pairs and tested across 37 unique cancer cells. The model's performance is tested using some metrics like mean square error ( <math><mrow><mi>MSE</mi></mrow> </math> ), mean absolute error ( <math><mrow><mi>MAE</mi></mrow> </math> ), coefficient of determination ( <math> <msup><mrow><mi>R</mi></mrow> <mn>2</mn></msup> </math> ), Spearman, and Pearson scores. The mean synergy scores of the proposed model are 232.37, 9.59, 0.57, 0.76, and 0.73 for the previous metrics, respectively. Also, the values for mean sensitivity scores are 15.59, 2.74, 0.90, 0.95, and 0.95, respectively.</p><p><strong>Conclusion: </strong>This paper proposes an MTDL model to predict synergy and sensitivity scores for drug combinations targeting specific cancer cell lines. The MTDL model demonstrates superior performance compared to existing approaches, providing better results.</p>","PeriodicalId":8958,"journal":{"name":"BMC Bioinformatics","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11468365/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Bioinformatics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1186/s12859-024-05925-0","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Drug combination treatments have proven to be a realistic technique for treating challenging diseases such as cancer by enhancing efficacy and mitigating side effects. To achieve the therapeutic goals of these combinations, it is essential to employ multi-targeted drug combinations, which maximize effectiveness and synergistic effects.

Results: This paper proposes 'MultiComb', a multi-task deep learning (MTDL) model designed to simultaneously predict the synergy and sensitivity of drug combinations. The model utilizes a graph convolution network to represent the Simplified Molecular-Input Line-Entry (SMILES) of two drugs, generating their respective features. Also, three fully connected subnetworks extract features of the cancer cell line. These drug and cell line features are then concatenated and processed through an attention mechanism, which outputs two optimized feature representations for the target tasks. The cross-stitch model learns the relationship between these tasks. At last, each learned task feature is fed into fully connected subnetworks to predict the synergy and sensitivity scores. The proposed model is validated using the O'Neil benchmark dataset, which includes 38 unique drugs combined to form 17,901 drug combination pairs and tested across 37 unique cancer cells. The model's performance is tested using some metrics like mean square error ( MSE ), mean absolute error ( MAE ), coefficient of determination ( R 2 ), Spearman, and Pearson scores. The mean synergy scores of the proposed model are 232.37, 9.59, 0.57, 0.76, and 0.73 for the previous metrics, respectively. Also, the values for mean sensitivity scores are 15.59, 2.74, 0.90, 0.95, and 0.95, respectively.

Conclusion: This paper proposes an MTDL model to predict synergy and sensitivity scores for drug combinations targeting specific cancer cell lines. The MTDL model demonstrates superior performance compared to existing approaches, providing better results.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多任务图深度学习模型,用于预测协同作用和敏感性得分的药物组合。
背景:事实证明,联合用药是治疗癌症等具有挑战性疾病的现实技术,既能提高疗效,又能减轻副作用。为了实现这些联合疗法的治疗目标,必须采用多靶点药物组合,以最大限度地提高疗效和协同效应:本文提出的 "MultiComb "是一种多任务深度学习(MTDL)模型,旨在同时预测药物组合的协同作用和敏感性。该模型利用图卷积网络来表示两种药物的简化分子输入线段(SMILES),生成它们各自的特征。此外,三个完全连接的子网络还能提取癌细胞系的特征。然后,这些药物和细胞系特征被连接起来,并通过注意力机制进行处理,从而为目标任务输出两个优化的特征表示。交叉缝合模型学习这些任务之间的关系。最后,将每个学习到的任务特征输入全连接子网络,以预测协同性和敏感性得分。我们使用 O'Neil 基准数据集对所提出的模型进行了验证,该数据集包含 38 种独特的药物,组合成 17,901 对药物组合,并在 37 种独特的癌细胞中进行了测试。该模型的性能测试采用了一些指标,如均方误差(MSE)、平均绝对误差(MAE)、决定系数(R 2)、斯皮尔曼和皮尔逊评分。在上述指标中,拟议模型的平均协同得分分别为 232.37、9.59、0.57、0.76 和 0.73。此外,平均灵敏度得分分别为 15.59、2.74、0.90、0.95 和 0.95:本文提出了一种 MTDL 模型,用于预测针对特定癌细胞系的药物组合的协同作用和敏感性得分。与现有方法相比,MTDL 模型表现出更优越的性能,提供了更好的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Bioinformatics
BMC Bioinformatics 生物-生化研究方法
CiteScore
5.70
自引率
3.30%
发文量
506
审稿时长
4.3 months
期刊介绍: BMC Bioinformatics is an open access, peer-reviewed journal that considers articles on all aspects of the development, testing and novel application of computational and statistical methods for the modeling and analysis of all kinds of biological data, as well as other areas of computational biology. BMC Bioinformatics is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We offer an efficient, fair and friendly peer review service, and are committed to publishing all sound science, provided that there is some advance in knowledge presented by the work.
期刊最新文献
Rare copy number variant analysis in case-control studies using snp array data: a scalable and automated data analysis pipeline. Mining contextually meaningful subgraphs from a vertex-attributed graph. Robust double machine learning model with application to omics data. A mapping-free natural language processing-based technique for sequence search in nanopore long-reads. Closha 2.0: a bio-workflow design system for massive genome data analysis on high performance cluster infrastructure.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1